Recent publication

Check out my lastest publication on Allergic bronchopulmonary aspergillosis in the Journal of Allergy and Asthma.  It looks at patients with a severe from of asthma caused by mold sensitivity who were treated with Xolair (omalizumab).  We showed that there was a decrease in oral corticosteroid use in these patients.  Using xolair might be an additional treatment modality for this difficult to treat group.

http://www.dovepress.com/articles.php?article_id=11467

http://www.dovepress.com/articles.php?article_id=11467

I hope you find it interesting and helpful.